5247.KLSE Karex Berhad
- Market cap
- MYR 437M
- P/E
- -
- P/B
- 0.97x
- ROE
- 0.1%
- Dividend yield
- 2.41%
- Fundamental score
- 1.8/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is 5247.KLSE undervalued?
Graham numberThe Graham number of Karex Berhad cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Karex Berhad fundamental analysis
10 of 22 checks passedROE 0/2
Low return on equity (0.1%), below 10%.
ROA 1/1
Return on assets (0.0%) is above the industry median (-0.1%).
Profit Consistency 1/2
Profitable for 4 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (39.9%) is above the industry median (-46.9%).
Revenue Growth 0/2
Revenue shrank 4.6% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (51.4%), up to 100%.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 0/1
EBIT is 1.0x against interest expense, below 5x.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (1.0x) is above the industry median (0.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 1/2
Dividend yield (2.4%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 0/1
Payout ratio is 3,619.9%, above 90% of earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About Karex Berhad
Karex Berhad, an investment holding company, manufactures and sells condoms in Malaysia. The company provides personal lubricants; probe covers; and catheters for transurethral drainage of the urinary bladder, as well as gloves. It also offers hand sanitizer and pre-vulcanised latex products. In addition, the company engages in wholesale healthcare product related business. Karex Berhad operates in the Americas, Asia, Europe, and Africa. Karex Berhad serves brand owners, gov…
Full company profileKarex Berhad financial statements
Karex Berhad annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 361M | 408M | 378M | 395M | 420M | 422M | 532M | 508M | 498M | 462M |
| Gross Profit | 111M | 106M | 89.2M | 87.7M | 97.7M | 92.6M | 136M | 171M | 155M | 143M |
| Operating Income | 35.5M | 14.0M | 4.21M | 7.17M | 1.94M | -2.86M | 22.4M | 39.5M | 7.91M | 9.35M |
| EBITDA | 49.8M | 29.5M | 20.9M | 28.5M | 25.1M | 20.9M | 49.4M | 65.3M | 36.5M | 37.6M |
| Net Income | 27.9M | 10.1M | 2.53M | 228K | -1.02M | -6.19M | 10.5M | 23.4M | 208K | 291K |
| EPS | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | -0.01 | 0.01 | 0.02 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 594M | 584M | 595M | 622M | 675M | 691M | 722M | 709M | 764M | 774M |
| Total Liabilities | 95.6M | 100M | 103M | 137M | 209M | 233M | 245M | 226M | 298M | 327M |
| Shareholders' Equity | 497M | 483M | 491M | 480M | 466M | 458M | 477M | 483M | 466M | 446M |
| Cash & Short-term Investments | 84.4M | 47.2M | 62.2M | 45.0M | 52.7M | 20.4M | 31.7M | 39.0M | 33.2M | 37.9M |
| Total Debt | 21.4M | 27.8M | 33.7M | 52.5M | 116M | 124M | 157M | 140M | 211M | 229M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 19.1M | 3.29M | 32.3M | 28.0M | 16.2M | 554K | 6.97M | 71.1M | 21.9M | 50.6M |
| Capital Expenditure | 59.9M | 28.5M | 19.0M | 24.2M | 56.4M | 35.6M | 18.7M | 20.7M | 42.8M | 36.9M |
| Free Cash Flow | -40.8M | -25.2M | 13.2M | 3.81M | -40.2M | -35.0M | -11.7M | 50.4M | -21.0M | 13.7M |
| Ratios | ||||||||||
| ROE | 5.6% | 2.1% | 0.5% | 0.0% | -0.2% | -1.4% | 2.2% | 4.9% | 0.0% | 0.1% |
| ROA | 4.7% | 1.7% | 0.4% | 0.0% | -0.2% | -0.9% | 1.5% | 3.3% | 0.0% | 0.0% |
| Net Profit Margin | 7.7% | 2.5% | 0.7% | 0.1% | -0.2% | -1.5% | 2.0% | 4.6% | 0.0% | 0.1% |
| Debt to Equity | 0.04x | 0.06x | 0.07x | 0.11x | 0.25x | 0.27x | 0.33x | 0.29x | 0.45x | 0.51x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Karex Berhad dividends
- Dividend yield
- 2.41%
- Forward dividend
- 0.01 MYR
- Payout ratio
- 3,619.9%
- Ex-dividend date
- Sep 10, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | MYR 10.5M | 0.01 | 3,619.9% |
| 2025 | MYR 10.5M | 0.01 | 5,064.4% |
| 2024 | MYR 15.8M | 0.01 | 67.4% |
| 2023 | - | - | - |
| 2022 | MYR 5.01M | 0.00 | - |
| 2021 | MYR 5.01M | 0.00 | - |
| 2020 | MYR 15.0M | 0.02 | 6,594.7% |
| 2019 | MYR 5.01M | 0.01 | 197.9% |
| 2018 | MYR 10.0M | 0.01 | 99.2% |
| 2017 | MYR 20.0M | 0.02 | 71.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 3:2 on Apr 15, 2016.
Who owns Karex Berhad
- Insiders 60.32%
- Institutions 14.41%
- Public & others 25.27%
- Shares outstanding 1.05B
- Free float 443M
Karex Berhad company profile
- Company name
- Karex Berhad
- Ticker
- 5247.KLSE
- ISIN
- MYL5247OO001
- Exchange
- Kuala Lumpur Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 2,987
- Fiscal year end
- June
- Address
- Persiaran Raja Lumu, Port Klang, Malaysia, 42000
- Phone
- 60 3 3165 6688
- Website
- karex.com.my
About Karex Berhad
Karex Berhad, an investment holding company, manufactures and sells condoms in Malaysia. The company provides personal lubricants; probe covers; and catheters for transurethral drainage of the urinary bladder, as well as gloves. It also offers hand sanitizer and pre-vulcanised latex products. In addition, the company engages in wholesale healthcare product related business. Karex Berhad operates in the Americas, Asia, Europe, and Africa. Karex Berhad serves brand owners, governments, non-governmental organizations, and retail purchasers. The company was founded in 1988 and is based in Port Klang, Malaysia.
Karex Berhad management
7- Mr. Miah Kiat GohCEO & Executive Director · born 1978
- Mr. Leng Kian GohExec Director of Technical, R&D and Non-Independent Non-Executive Director · born 1955
- Mr. Your Can WongChief Strategy & Financial Officer · born 1977
- Ms. Lai Peng LimChief Innovation Officer · born 1980
- Madam Yit Chan Tai MAICSACompany Secretary
- Ai Ning TanCompany Secretary
- Siew Hong TanCompany Secretary